Sofosbuvir as treatment against dengue?
Dengvaxia® (CTD-TDV), the only licensed tetravalent dengue vaccine by Sanofi Pasteur, was made available since 2015. However, administration of CTD-TDV, in general, has not received the prequalification recommendation from the World Health Organization. Having a universal antidengue agent for treatm...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
Wiley
2017
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/22051/ https://doi.org/10.1111/cbdd.13091 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|